We developed techniques to assess the utility of a nuclear magnetic resonance (NMR) indicator for cerebral blood flow studies in cats, using Freon-22 for the first candidate. A PIN-diodeswitched NMR experiment allowed the acquisition of an arterial as well as a cerebral fluorine-19 signal proportional to concentration vs. tune in a 1.89 T magnet. Mean±SD blood:brain partition coefficients for Freon-22 were estimated at 0.93±0.08 for gray matter and 0.77±0.12 for white matter. Using maximum-likelihood curve fitting, estimates of mean±SD resting cerebral blood flow were 50±19 ml/100 g-min for gray matter and 5.0±2.0 ml/100 g-min for white matter. Hypercapnia produced the expected increases in gray and white matter blood I n vivo phosphorus-31 and hydrogen-1 nuclear magnetic resonance (NMR) spectroscopy employing surface coils has rapidly found a place in the dynamic monitoring of brain metabolism in models of cerebral ischemia. A technique that could measure cerebral blood flow (CBF) in conjunction with these NMR measurements of metabolism would be very useful. To this end, we have performed a surface coil NMR experiment in which an indicator dilution technique was employed, with fluorine-19 ( 19 F) as an indicator. We report the apparatus, methods, and results and propose this approach as suitable for testing other 19 F blood flow indicators.
I
n vivo phosphorus-31 and hydrogen-1 nuclear magnetic resonance (NMR) spectroscopy employing surface coils has rapidly found a place in the dynamic monitoring of brain metabolism in models of cerebral ischemia. A technique that could measure cerebral blood flow (CBF) in conjunction with these NMR measurements of metabolism would be very useful. To this end, we have performed a surface coil NMR experiment in which an indicator dilution technique was employed, with fluorine-19 ( 19 F) as an indicator. We report the apparatus, methods, and results and propose this approach as suitable for testing other 19 F blood flow indicators.
Materials and Methods
Because the I9 F NMR signal of Freon-22 was to be used as a measure of indicator concentration, we avoided the use of fluorinated anesthetic agents. Eight cats, all females weighing >3 kg, were anesthetized with 20 mg/kg ketamine and 1.5 mg/kg xylazine for induction and subsequent surgery and then maintained on 2 mg/kg i.v. ketamine and 5 mg/ kg i.v. thiopental every 40 minutes; this strategy for anesthesia in dogs has been reported 1 to produce a stable CBF of approximately 80% of normal values. Figure 1 shows the surgical preparation of each cat. The cranial muscles were reflected, and a 2-cm-diameter surface coil was cemented to the skull. One femoral artery and one femoral vein were cannulated, and arterial blood was led through a 5-mm-i.d. six-turn solenoid coil and returned to a vein. This arrangement allowed the near-simultaneous measurement of both the arterial and cerebral signal of Freon-22, permitting the calculation of clearance times of the indicator in the brain. The other femoral artery and vein were cannulated for the measurement of blood pressure and blood gases and to permit the infusion of fluids or drugs as necessary. After surgery, each cat was placed in a nonmagnetic animal holder, which was then centered in the magnet.
All cats were ventilated with a gas mixture of 50% O 2 and 50% N 2 during nonstudy normocapnic conditions and 50% O 2 , 45% N 2 , and 5% CO 2 for nonstudy hypercapnic conditions. When CBF was measured, the gas mixture was switched to 50% O 2 , 45% Freon-22, and 5% N 2 during normocapnia or 50% O 2 , 45% Freon-22, and 5% CO 2 during hypercapnia for approximately 6 minutes. At 6 minutes, N 2 was substituted for the Freon-22 so that both the uptake and the clearance of indicator could be followed in the cerebral tissue.
After completion of the experiment, each cat was killed and the brain was removed for gross morphologic observation and measurement of brain solubilities (see below). All NMR experiments were carried out using a 60-cm clear-bore 1.89 T topical magnetic resonance 2 magnet at a I9 F frequency of 75.60 MHz using a Bruker Instruments, Inc. Biospec console (Billerica, Massachusetts). The NMR spectrum of Freon-22 is a doublet (Figure 2 ). The middle spectrum in Figure 2 was obtained from whole brain saturated with Freon-22 and placed in an 8-mm NMR tube, with 80 mM trifluoroacetic acid as an external standard placed in a concentric capillary tube. The Freon-22 doublet in brain is considerably broadened compared with that of Freon-22 in water (bottom spectrum, Figure 2 ). The upper spectrum is that of Freon-22 dissolved in olive oil, from which it can be seen that there is a frequency shift of Freon-22 in oil compared with that of Freon-22 in water. Similar NMR measurements were made in whole blood from cats. When the total signal under either the brain or blood curve was integrated and compared with the standard, a preliminary NMR estimate of the relative solubilities of Freon-22 in brain and blood could be obtained.
PIN diodes
3 were used to switch between the arterial coil and the head coil, with switching times on the order of microseconds. PIN diodes (so-called because of their P-material, Intrinsic, N-material sandwich-type construction) are semiconductor devices that act as variable resistors at radio frequencies (RF). When a PIN diode is forwardbiased, it will pass current in either direction with very little distortion or added noise. In the reversebias mode, almost no current is passed (up to the breakdown voltage of the diode). Thus, PIN diodes can be used as switches to effectively isolate NMR RF coils using the same transmitter and receiver. The fast switching times of PIN diodes made possible the interleaving of NMR signals from arterial and cerebral experiments.
If only the tissue concentration of 19 F changed over time, regardless of the volume of tissue studied, then changes in the 19 F signal intensity in the NMR experiment would be directly proportional to the quantity of Freon-22 in the tissue. Thus, the signal from the arterial coil was directly propor- tional to systemic arterial concentration of Freon-22. The case for the surface coil (placed on the head) was more complicated; since the tissue volume occupied by cerebral blood vessels is <5%, 4 T, of the I9 F signal for Freon-22 in blood is longer than that in brain (leading to a saturated blood signal), and since the scalp and temporal muscles of the cat were reflected well away from the surface coil, the signal we measured originated almost entirely from the gray and white matter of the brain.
NMR parameters were adjusted to yield the maximum signal. Repetition times of 64 msec for each coil and a total of 128 acquisitions per coil per sampling interval were selected. In each experiment, with disk reads and writes taken into account, 128 acquisitions of data could be made in 12 seconds. The free induction decays (FIDs) accumulated during each interval were exponentially multiplied (line broadening of % Hz), and a magnitude calculation was performed. For each sample in a CBF study, the absolute magnitude of the accumulated line-broadened spectrum was integrated across a window with a width three times the full width at half-maximum of the signal, determined when it had reached its maximum intensity. This integral was the quantity used as an estimate of the cerebral concentration (C(t) in Equation 1).
Before fitting the curve, the arterial input function was smoothed slightly with a Hanning digital filter to suppress high-frequency variations. This was necessary because noise in the arterial and head curves were correlated, one source of noise being "pickup" from external sources of RF interference. Without preliminary smoothing, artifactually high CBF would have been estimated by curvefitting.
The theory of indicator dilution measurements of CBF has been well described. 5 -10 Normally, CBF has two distinct compartments of flow, those of the gray and white matter. Accordingly, the timedependence of the indicator's concentration in cerebral tissue, as measured by the signal in a surface coil, can be represented as where C(t) is the processed NMR signal from the head coil, integrated across a window with a width three times the full width at half-maximum of the signal (this signal is proportional to the tissue concentration of the indicator); W, is a proportionality constant that includes the relative contribution (weight) of the /th tissue compartment to the NMR signal in the surface coil and the efficiency of detection of the indicator in the /th tissue compartment; P, is a proportionality constant, W, times scaling differences between the amplitude of the arterial signal for a given concentration and the tissue signal; C,<t) is the tissue concentration of indicator in the /th tissue compartment as a function of time; k, is the clearance constant of the /th tissue compartment; C a (t) is the arterial concentration of the indicator; and S n is the additive baseline noise; S n would be the background count if a radioactive indicator were used.
As usual, blood flow in the /'th compartment can be calculated as f/=k,A, where f, is the specific flow in milliliters per 100 grams per minute in the /th tissue compartment and A, is the brain:blood partition coefficient for the /th tissue compartment.
The measured quantities are the arterial input and the cerebral response as functions of time. CBF was inferred by nonlinear estimation, in which the parameters were iteratively adjusted to yield a "best fit" of the response curve given the input function. In eight of 16 CBF studies, the four unknown parameters k,, k 2 , Pi, and P 2 were simultaneously estimated, with S n being determined by averaging the initial portion of the head curve (before the start of administration of Freon-22). In the other eight studies, the initial (indicator-free) portion of the head curve did not permit a sufficiently precise estimate of S n . In these studies, it was necessary to include S n in the maximum likelihood 10 procedures and to simultaneously estimate five parameters to obtain satisfactory curve fits. The four-parameter case was chosen when possible since this produced smaller errors in estimating the model parameters.
The Van Slyke method 1112 of estimating the brain:blood partition coefficient was used rather than an NMR experiment so that the possible loss in an NMR experiment of "F signal due to shortening (broadening) of the time (frequency) domain signal in the brain relative to the signal in the blood could be avoided. Brains were removed from 3-5-kg ketamine-anesthetized cats and immediately stored in cold isotonic saline for later use. Gray and white matter were dissected, minced, diluted with varying amounts of distilled water for ease of handling in the apparatus, and homogenized in a Birmingham homogenizer (Brinkmann Instruments, Inc., Westbury, New York). The brain-water homogenate was then transferred to a 50-ml Erlenmeyer flask, and humidified nitrogen gas was bled through the flask for at least 1 hour to purge the homogenate of gases other than nitrogen; 1.4 ml of the homogenate was then transferred to a constant-temperature bath, where it was allowed to equilibrate to 37° C. Three milliliters of Freon-22 at standard temperature and pressure was sampled in a gas-tight glass syringe (Precision Sampling Corp., Baton Rouge, Louisiana) and transferred to the chamber of the Van Slyke apparatus, where it was allowed to equilibrate to 37° C. After the pressure of the Freon-22 in a 2-ml volume was measured, the brain-water sample was injected into the chamber of the Van Slyke apparatus, and the apparatus was gently shaken while the pressure of the gas above the brain-water sample was held at approximately 1 atmosphere. Pressure at a constant 2 ml was measured intermittently until pressure equilibrium was reached (usually <20 minutes).
Varying amounts of water were used to dilute the brain sample: 30-90% by volume for gray matter and 50-90% for white matter. Blood was treated in a similar manner, but since it was not so viscous as to present difficulty in handling, no dilution was necessary. For each brain, solubility of Freon-22 in the tissue was then calculated as the zero intercept of a least-squares regression line of solubility vs. percent water. By these means a direct measurement of the solubility of Freon-22 in blood and water and an extrapolated estimate of the solubility of Freon-22 in gray and white matter was available. The brain:blood partition coefficient was then calculated by dividing the extrapolated solubility of Freon-22 in brain at 37° C by the solubility of Freon-22 in blood at 37° C.
In previous experiments on 10 cats in which a-chloralose was used as an anesthetic, 13 there was no significant effect of Freon-22 on CBF measured by Kety-Schmidt techniques. However, since achloralose depresses CBF in cats (unpublished data), we investigated this matter again using the ketamine/ thiopental anesthetic regimen.
Six cats were surgically prepared as in the NMR experiment. A small hole was bored in each cat's skull, and the sagittal venous sinus was cannulated to obtain samples of cerebral venous blood. Arterial blood was sampled from the femoral artery. In the control condition, the cat was allowed to equilibrate breathing a gas mixture of 50% O 2 ,40% N 2 , and 10% N 2 O for at least 1 hour. In the test condition, during the hour in which CBF was determined and for 10 minutes before time t=0, 40% Freon-22 replaced the N 2 . At t=0, N 2 O was replaced by N 2 and arterial and venous blood samples were taken simultaneously at t=0, 30, 60, and 90 seconds and 2, 3, 4, 5, 7, 9, 12, 15, 25, 35, 45, and 60 minutes. At t=60 minutes, the blood samples were analyzed for N 2 O concentration in a modified trace N 2 O monitor (Spectrum Co., Grand Rapids, Michigan) and CBF was calculated by standard practices that produce a wellaccepted and model-independent estimate of CBF. 1415 
Results
In preliminary in vitro experiments, the mean±SD blood:brain partition coefficient estimated by NMR methods was 1.09±0.12 for whole brain. The results of a larger series of Van Slyke determinations of the solubility of Freon-22 in gray matter, white matter, blood, and water at 37° C are provided in Table 1 . These measurements estimate the extrapolated brain: blood partition coefficient for Freon-22 in gray matter to be 0.93±0.08 and in white matter to be 0.77+0.12.
In Figure 3 the arterial input function and the cerebral response as measured by the integral of the exponentially weighted FIDs are plotted against time, along with the maximum-likelihood curve fit. Table 2 presents the fitted mean±SD and the noise of parametric estimates for a two-compartment flow model. Using the Van Slyke estimates of the brain:blood partition coefficient, mean±SD blood flow for gray matter was 50±19 ml/100 g-min and for white matter was 5.0±2.0 ml/100 g-min in the normocapnic group (PacOj=31.3±3.5 mm Hg). Gray matter blood flow rose to 83 ±32 ml/100 g-min and white matter blood flow to 7.7±3.3 ml/100 g-min in the hypercapnic group (Paco 2 =52.2±3.3 mm Hg). The mean±SD resting CBF (32±12 ml/100 g-min) measured by Freon-22 clearance and uptake was not significantly different from that of 40±14 ml/100 g-min measured by Kety-Schmidt methods (r=1.3, df=\2, two-tailed p>0.2). (In Kety-Schmidt CBF determinations, the blood:brain partition coefficient for N 2 O in cat brain was taken as 1.08.
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The time from induction of anesthesia to control CBF studies in Kety-Schmidt determinations of CBF was less (3.0± 1.0 hours) than with NMR CBF studies (5.7±2.4 hours). This is a direct result of the higher degree of experimental complexity involved in the NMR experiment. We hypothesize that the longer time necessary to perform the NMR study led to a trend toward lower CBF measurements. When analyzed for correlation, fast-flow CBF and length of the experiment covaried with the hypothesized negative coefficient (r= -0.66, df=f>, p<0.01). Fast-flow CBF was also negatively correlated with the number of doses of thiopental that the cat received before the study.
Although it is not metabolized 16 and has a relatively low acute toxicity 17 even in concentrations as high as 40% by volume in inspired air, Freon-22 still produces a number of side effects. A period of hypotension and bradycardia usually followed the beginning of the administration of 40% Freon-22 to ketamine/thiopental-anesthetized cats, and tachycardia often followed its washout. This was consistent with previous reports for rabbits and mice, 1819 dogs, 20 and monkeys.
-
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CBF also changed with Freon-22 administration. Figure 4 shows an example of typical data from a Kety-Schmidt N 2 O experiment in a cat (control versus administration of 40% Freon-22). Blood flow values for all six cats are summarized in Table 3 . Using a paired t test, we found the two conditions to be significantly different (/=4.7, dj=5, p<0.01). Since the two experiments were quite similar except for the administration of Freon-22 (Pacc^ in the two conditions was virtually identical), we conclude that the administration of 40% Freon-22 for periods of ^10 minutes increases mean CBF by approximately 50%. Discussion Several laboratories have reported progress in developing an NMR indicator dilution technique using Freons. In one report, clearance rates of indicator in rat brain under conditions of normocapnia and hypercapnia were reported, 23 with blood: brain partition coefficients estimated by brain biopsy in living rats. These coefficients were reported to be 0.5 for whole brain, with no error estimates included. As an indication of the procedure's promise, it was shown that the hypercapnic clearance rates were higher than the normocapnic clearance rates. In another report, 24 Freon-22 was examined briefly as a potential NMR indicator in cats and then discarded in favor of Freon-23 since electroencephalographic (EEG) changes were observed for Freon-22 but not for Freon-23 administration. Blood:brain partition coefficients of 1.4, assessed by brain biopsy, were reported for both fluorocarbons, with no estimates of errors included. In neither report was the arterial input function measured simultaneously with the uptake and/or clearance of the indicator, nor were biexponential clearance curves observed. In a preliminary study, 13 we reported a series of Freon-22 experiments in a-chloralose-anesthetized cats in which an arterial input and head NMR signal were simultaneously observed. The mean±SD blood: brain partition coefficient was estimated by NMR to be 1.09±0.12 for whole brain. However, because a-chloralose so profoundly depressed the CBF in these cats, only monoexponential clearance curves were observed; hence there was no localization of where CBF was being measured.
Because it is a relatively inexpensive gas with a strong NMR signal, Freon-22 served well in the development of a template that might be used in testing less commonly available indicators. We refined ways of inferring CBF values from serial accumulations of NMR FIDs. We adapted maximumlikelihood techniques previously used in the analysis of xenon-133 inhalation data to fit both the uptake and clearance of the processed NMR data. Data are mean±SD. N, normocapnia; H, hypercapnia; conditions presented in order of study; Lag, time between arrival of indicator at arterial coil and its arrival at head coil. Mean±SD fast flow in normocapnia: 50± 19 ml/100 g-min; mean±SD fast flow in hypercapnia: 83±32 ml/100 g-min; mean±SD flow for both compartments: 32±12 ml/100 g-min.
•Values without errors were estimated from noise in initial portion of head curve rather than being iteratively fitted.
With the change in anesthetic regimen in the cat model, we observed and fitted two-compartment cerebral clearance curves. To our knowledge, this is the first time that such two-compartment fits are reported in an NMR indicator dilution experiment. By virtue of the bicompartmental clearance curves, the question of where the CBF is being measured can be answered in a physiologic sense; approximately two-thirds of the total indicator signal that clears appears to come from the fast-flow (gray matter) compartment. We estimated the solubility of Freon-22 in water, blood, gray matter, and white matter. Previous determinations 2526 of its solubility in water have yielded similar figures. In particular, an interpolation of the values of Reference 18 to 37° C yields an estimate of 34.9x 10~6 g-mol/1-mm Hg compared with our estimate of 40.5 x l(T*±6.0 g-mol/1-mm Hg. Thus, the value we measured for water was in good agreement with previously published figures and lent credibility to the values we measured for other substances. We calculated brain:blood partition coefficients from Van Slyke solubility measurements; the coefficient for gray matter was approximately 0.93 and that for white matter was approximately 0.77. These estimates are supported by a previous investigation in which tissue concentrations after inhalation of Freon-22 were determined in various rabbit tissues, including brain and blood, 18 by head-space gas chromatography after death. The authors note that "values varied somewhat because is very volatile and some evaporated during autopsy and treatment for analysis." Nevertheless, the partition coefiicient calculated from the values given for eight rabbits was 0.80±0.18 for whole brain.
In Freon-22 CBF measurements, fast-flow (gray matter) compartment rates determined from maximum-likelihood techniques yielded values somewhat lower than those measured by xenon-133 intra-arterial injection in N 2 O-anesthetized cats.
2728
Cortical values were lower than those measured by H 2 uptake in ketamine-anesthetized cats 29 and lower than H 2 clearance and microsphere measurements 30 in pentobarbital-anesthetized cats. In addition, our calculations led to values lower than expected on the basis of direct (timed cerebral venous effluent) measurements of whole-brain CBF in dogs under ketamine/thiopental anesthesia. 1 Thus, our techniques lead to estimates of CBF that may be biased low but that have the signature of a CBF measurement, which is reactivity to CO 2 . At least part of this low bias is explained by the 6-8-hour length of the experiment and the repeated doses of thiopental that the cats received, compared with that of the Kety-Schmidt procedures.
CBF was increased by the administration of Freon-22. This increase was accompanied by other physiologic changes such as slowing of the EEG (previously reported 5 ), bradycardia, acute arterial hypotension, and increases in intracranial pressure. One requirement of an indicator for measurement of CBF is that it be physiologically inert. Therefore, Freon-22 is not an ideal indicator in NMR CBF measurements, despite the facts that the measured CBF values were consistent with Kety-Schmidt values and CBF reactivity to CO 2 was preserved. Since in a-chloralose-anesthetized cats the activating effects of Freon-22 were much less, 13 the possibilities that Freon-22 interacts with the anesthetic agents used or that in lower concentrations or during shorter administration times it might have less effect cannot be ruled out. Mean±SD control flow 40±14 ml/100 g-min.
Despite the shortcomings of Freon-22 as an NMR CBF indicator, we provide a template of methods by which other l9 F-containing compounds, such as Freon-23, may be evaluated. Two relatively simple adjustments need to be made before these techniques can be extended to humans: first, a physiologically less active fluorinated indicator needs to be identified and second, a method for the atraumatic estimation of arterial indicator concentrations needs to be developed. Preliminary investigations have shown progress in both areas. First, a promising indicator has been identified in Freon-23, which is nontoxic and is considered a simple asphyxiant. Preliminary measurements of EEG, electrocardiogram, and CBF in anesthetized cats during administration of 60% Freon-23 by volume showed no changes. So far, the administration of Freon-23 to humans in concentrations high enough to yield good signal-to-noise ratios appears quite feasible. be measured using this instrument and, presumably, this will eventually allow the elimination of a direct measurement of arterial indicator concentrations. It is apparent that rapid progress is being made toward an NMR indicator dilution measurement of CBF in humans. Using PIN switches, the interleaving of CBF measurements with phosphorus-31 or hydrogen-1 NMR spectroscopy is achievable with these techniques. Thus, a full set of physiologically important measurements (energy levels, pH, rCBF, and, using proton spectroscopy, lactate concentrations) may soon be simultaneously available by NMR means in both animals and humans for evaluating cerebral metabolic states.
